ArticleFrontiers in cell and developmental biology2026
Integrated analysis of cell-in-cell related genes and immune microenvironment in heart failure.
Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Heart failure (HF) is a major global public health challenge, and its pathogenesis involves the regulation of a complex immune microenvironment (IME). Cell-in-cell (CIC), as a non-classical form of cell-cell interaction, has been extensively studied in fields like oncology, but its role in HF remains unclear. This study aimed to systematically analyze the expression patterns and functions of CIC-related genes (CRGs) within the HF immune microenvironment. Methods: Based on transcriptomic data from public databases, CIC-related differentially expressed genes (DEGs) between HF and healthy samples were identified. Three machine learning algorithms-Random Forest, LASSO, and SVM-RFE-were employed to screen diagnostic markers and construct a nomogram model. Consensus clustering analysis was used to stratify HF patients into distinct subtypes based on CRG expression, and their immune infiltration characteristics were compared. Single-cell transcriptomic data were utilized to validate the cellular localization of key genes within the HF microenvironment. Experimental validation of key CRGs was performed using a transverse aortic constriction (TAC)-induced HF rat model. Results: A total of 21 CIC-related DEGs were identified. A diagnostic model comprising 10 core genes demonstrated high predictive performance in both the training and validation sets. Based on CRG expression, HF patients were classified into two subtypes: Subtype A was enriched with regulatory T cells and M2 macrophages, exhibiting an immunosuppressive and fibrotic phenotype; Subtype B was dominated by cytotoxic T cells and NK cell infiltration, displaying an immune-activated phenotype. Single-cell analysis revealed high expression of CTSK in fibroblasts and enrichment of GZMB in T/NK cells. Animal experiments confirmed the upregulation of LPAR2 and GZMB and the downregulation of IL-10 in the TAC model. Conclusion: CIC-related genes possess significant diagnostic value in HF and can distinguish HF subtypes with distinct immune microenvironment features. CRGs may participate in HF progression by regulating immune cell infiltration and fibrotic processes, providing a new perspective for understanding HF heterogeneity and developing targeted immunotherapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.